InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: biotech_researcher post# 187701

Thursday, 04/18/2019 10:04:10 AM

Thursday, April 18, 2019 10:04:10 AM

Post# of 429528
Just following IBB, once that gets oversold and bounces so will Amarin, but also think after priority review news we should see a small bounce. Even if IBB stays down, at some point the rapidly growing revenue and FDA approval will disconnect AMRN from the sector.
Investors are trading biotech sector like Bernie Sanders was elected and implemented Medicare for all, and limited prices on prescription drugs. None of that will happen and sector will take some time to realize this is overdone. Not buying opp. yet but will be a good sector buying opp. over the next couple months.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News